Scopus BioPharma (SCPS) Stock Statistics & Valuation Metrics
Total Valuation
Scopus BioPharma has a market cap or net worth of $16.83K. The enterprise value is -$107.74B.
- Market Cap
- $16.83K
- Enterprise Value
- -$107.74B
Share Statistics
Scopus BioPharma has 42,084,263 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 42,084,263
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Scopus BioPharma’s return on equity (ROE) is 1.77 and return on invested capital (ROIC) is 164.39%.
- Return on Equity (ROE)
- 1.77
- Return on Assets (ROA)
- -29.60
- Return on Invested Capital (ROIC)
- 164.39%
- Return on Capital Employed (ROCE)
- 1.66
- Revenue Per Employee
- 0
- Profits Per Employee
- -893.06K
- Employee Count
- 13
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Scopus BioPharma is -0.00. Scopus BioPharma’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Scopus BioPharma had revenue of 0 and earned -11.61M in profits. Earnings per share was -0.55.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -11.71M
- Pretax Income
- -11.71M
- Net Income
- -11.61M
- EBITDA
- -11.71M
- Earnings Per Share (EPS)
- -0.55
Cash Flow
In the last 12 months, operating cash flow was -3.04M and capital expenditures -1.55M, giving a free cash flow of -4.59M billion.
- Operating Cash Flow
- -3.04M
- Free Cash Flow
- -4.59M
- Free Cash Flow per Share
- -0.39
Dividends & Yields
Scopus BioPharma pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -48284.31%
- Earnings Yield
- -137594.60%
Stock Price Statistics
- Beta
- -90.08
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Scopus BioPharma as a current ratio of 0.05, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.05
- Quick Ratio
- 0.05
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.01
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Scopus BioPharma has paid -105.05K in taxes.
- Income Tax
- -105.05K
- Effective Tax Rate
- 0.01
Enterprise Valuation
Scopus BioPharma EV to EBITDA ratio is 0.01, with an EV/FCF ratio of 0.01.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.01
- EV to Free Cash Flow
- 0.01
- EV to Operating Cash Flow
- 0.01
Balance Sheet
Scopus BioPharma has $362.10K in cash and marketable securities with $0.00 in debt, giving a net cash position of $362.10K billion.
- Cash & Marketable Securities
- $362.10K
- Total Debt
- $0.00
- Net Cash
- $362.10K
- Net Cash Per Share
- $0.01
- Tangible Book Value Per Share
- -$0.26
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%